Abstract: A radiofrequency (RF) coil for use in a magnetic resonance imaging (MRI) system using a plurality of RF coils includes a main loop coil including a plurality of electrical conductors, and an auxiliary loop coil disposed around the plurality of electrical conductors and including a plurality of electrical conductors.

Abstract: One or more example embodiments relate to a device for treating ocular diseases caused by an increased intraocular pressure. The device for treating ocular diseases according to one or more example embodiments, compared to a conventional Ahmed valve implant and Baerveldt implant, does not require a donated tissue, reduces tube exposure danger, allows intraocular pressure to be easily controlled after surgery, has a slight effusion of aqueous humor to the surrounding due to a small perforated window, decreases the types and number of postoperative interventions, and decreases the number of patients with early postoperative complications.

Abstract: Disclosed herein are an X-ray imaging apparatus and a method for controlling the same. The X-ray imaging apparatus includes an X-ray generator configured to radiate first-energy X-rays toward an object, an X-ray detector configured to detect the first-energy X-rays which propagate through the object, an image processor configured to generate a first object image which correspond to the detected first-energy X-rays and to estimate a second object image which corresponds to second-energy X-rays based on the generated first object image, and a controller configured to control the image processor to repeatedly estimate the second object image by controlling the X-ray generator to repeatedly radiate the first-energy X-rays toward the object.

Abstract: An apparatus and method for generating print data about a phantom customized to a patent, the apparatus receive medical images including anatomical information of a patient's body and treatment plan information about a dose distribution of a radiation to be irradiated to a treatment area, reconstructs a three-dimensional phantom image in which internal and external structures of the patient's body are modeled which are based on the anatomical information and in which a space for a dosimeter is modeled which is to be inserted into the internal and external structures so as to verify the dose distribution according to the treatment plan information, and generates print data for three-dimensional printing, which is used for manufacturing the phantom customized to the patient on the basis of the reconstructed three-dimensional phantom image.

Abstract: A quality assurance system for radiation therapy equipment includes an image capturing unit installed on radiation therapy equipment and capturing an image of an indicating part indicating an operational state of the radiation therapy equipment, an image processing unit extracting an edge of the indicating part in image captured by the image capturing unit, a center point extraction unit extracting a center point with respect to the edge, and a quality evaluation unit evaluating quality of the radiation therapy equipment by tracking movement of the center point.

Abstract: The present invention relates to novel peptides and use thereof and more specifically is directed to a peptide with anti-inflammatory effect, a polynucleotide encoding the peptide, a pharmaceutical composition comprising the peptide or polynucleotide for preventing or treating inflammatory diseases, an anti-inflammatory drug, an over-the-counter (OTC) drug composition comprising the peptide for preventing or ameliorating inflammation, a health food composition for alleviating or ameliorating inflammation, a cosmetic composition for preventing or ameliorating inflammation, a method for treating inflammatory diseases, comprising administrating the pharmaceutical composition to the subject suspected of having inflammatory disease, a method for preparing a mimetic of the peptide and a method for designing the same.

Abstract: The present disclosure relates to a method for more easily and economically producing a selenophene-fused aromatic compound derivative containing various substituents and the selenophene-fused aromatic compound produced according to the method, and the selenophene-fused aromatic compound can be used for various purposes such as an intermediate of an anti-bacterial or anticancer substance, an indicator of which color is changed depending on a solvent, or a fluorescent substance.

Abstract: Provided are a method and apparatus for accumulating positive frequency data. The method includes receiving result data of pooling tests performed on a plurality of pools on a two dimensional (2D) matrix, the pooling test result data including allele frequencies of positive pools for a standard variant, predicting the number of positive samples for the standard variant from the allele frequencies of the positive pools, calculating a positive frequency for the standard variant from the number of positive samples, and updating the positive frequency for the standard variant to positive frequency database.

Abstract: A method for detecting a pooling error including the steps of determining an expected number of normal chromosome strands of a plurality of samples contained in a first pool based on ploidy types of the plurality of samples, determining whether a number of normal chromosome strands is different from the expected number of chromosome strands determined based on base sequences of the plurality of samples contained in the first pool, determining whether pooling is equilibrated based on an allele frequency value for a standard variant of the first pool, and detecting a pooling error using results of the determining the number of normal chromosome strands and the determining whether the pooling is equilibrated.

Abstract: Provided are a method and apparatus for verifying pool test result. The method includes receiving pool test result data obtained by performing a pool test on a plurality of pools configured based on a two-dimensional (2D) matrix, the pool test result data including allele frequencies of the plurality of pools, extracting a pool-specific variant from the matrix using the allele frequencies determining whether there is an intersecting pool among pools intersecting, in the matrix, a pool showing the pool-specific variant and determining whether the pool test result data is erroneous based on results of the determining whether there is an intersecting pool.

Abstract: The present invention relates to a marker for predicting a gastric cancer prognosis, a composition and a kit for predicting gastric cancer prognosis comprising an agent for measuring the expression level thereof, and a method for predicting gastric cancer prognosis using the marker. According to the present invention, gastric cancer prognosis may be predicted promptly and accurately, and an appropriate treatment plan can be determined based on the predicted prognosis, which has an advantage of contributing to significant reduction of death caused by gastric cancer. Particularly, according to the present invention, the survival rate can be remarkably increased by using the treatment method for a stage III gastric cancer patient to a patient who has been predicted to have a negative prognosis among stage Ib/II gastric cancer patients.

Abstract: A system for manufacturing a patient-specific applicator reconstructs a three-dimensional (3D) image by using a medical image of a patient, models an applicator structure for irradiating radiation onto a tumor tissue, based on a 3D image, generates printing data for 3D printing for manufacturing the patient-specific applicator based on the modeled applicator structure, and manufactures the patient-specific applicator based on the generated printing data.

Abstract: The antibody of the invention has high specificity to human c-Met and is cross-reactive to mouse c-Met. The antibody or its antigen-binding fragment of the invention is capable of specifically binding to human c-Met as well as mouse c-Met, more accurate preclinical results can be confirmed in the efficacy evaluation using mouse tumor models. The antibody of the invention inhibits the growth of cancer cells derived from various cancers by a considerable binding affinity to c-Met and the suppression of c-Met function therefrom, inhibits the phosphorylation of c-Met and downstream signaling molecules to suppress c-Met signaling, and inhibits neovascularization, thereby being very efficient in the prevention and treatment of cancers.

Abstract: The present invention relates to a HSP27 mutation (S135F) mediated Charcot-Marie-Tooth disease (CMT) animal model. Particularly, the vector expressing mutant HSP27 protein wherein the 135th serine is substituted with phenylalanine has been injected in the mouse zygote and then the mouse harboring the expression vector was selected. The selected mouse was confirmed to display Charcot-Marie-Tooth disease phenotype, so that the animal model was expected to be efficiently used for the evaluation of the effect of Charcot-Marie-Tooth disease treating material candidates.

Abstract: The present invention relates to a method for the screening of a therapeutic agent for Charcot-Marie-Tooth disease (CMT) using induced pluripotent stem cells and motor neurons differentiated therefrom. Particularly, the present inventors prepared induced pluripotent stem cells from the human fibroblasts originated from CMT patient. When the motor neurons differentiated from the said induced pluripotent stem cells are used for the screening of a therapeutic agent for Charcot-Marie-Tooth disease, the pharmaceutical effect of the therapeutic agent candidates can be easily evaluated during the screening. In addition, by the method to prepare the induced pluripotent stem cells, autologous motor neurons which are usable for the screening of a patient-specific therapeutic agent and the patient-specific treatment can be prepared.

Abstract: There are provided a system and method for analyzing a biological sample.

Abstract: Provided is a medical imaging apparatus including: a scanner configured to obtain projection data of an object; a three-dimensional restoring module configured to restore a volume of the object based on the projection data; a volume segmentation module configured to segment a plurality of material volumes corresponding to a plurality of materials included in the object based on the volume of the object; a reprojection module configured to generate a plurality of reprojection images according to the plurality of materials by reprojecting the plurality of material volumes from a plurality of virtual viewpoints; and an image fusion module configured to generate a plurality of fusion images according to the plurality of virtual viewpoints, each of the plurality of fusion images being generated by fusing reprojection images according to plurality of materials obtained from the same virtual viewpoint.

Abstract: A cell analysis apparatus may include: an image processing unit imaging cultured cell colonies to convert the imaged cell colonies into digital signals; an outline extracting unit extracting outlines of the cell colonies from image data obtained from the image processing unit; a size calculating unit calculating sizes of the cell colonies from the extracted outlines; and a selecting unit comparing the sizes of the cell colonies with a preset value to select grown cell colonies.

Abstract: The present disclosure relates to a novel method for preparing selenyl-substituted aromatic aldehyde compounds by forming a selenolate nucleophile and performing a nucleophilic substitution reaction between the selenolate nucleophile and an aromatic aldehyde starting material.

Abstract: One embodiment of the present invention provides a detection kit for detecting c-Met gene expression, wherein the detection kit includes a primer set which is specifically bound to the c-Met gene; and a cleavable probe which is specifically bound to the inside of a c-Met gene amplification product which is amplified by the primer set. Another embodiment of the present invention provides a method of measuring the c-Met gene expression by using the detection kit according to one embodiment of the present invention. The method according to one embodiment of the present invention is used to efficiently detect a low concentration of c-Met gene expression for cancer diagnosis and prognosis diagnosis.